A Phase Ⅱ Study of F520 in Patients With Urothelial Carcinoma
Condition(s):Locally Advanced or Metastatic Urothelial Cell CarcinomaLast Updated:November 19, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):Locally Advanced or Metastatic Urothelial Cell CarcinomaLast Updated:November 19, 2020Unknown status
Condition(s):Bladder CancerLast Updated:September 28, 2023Recruiting
Condition(s):Urothelial Carcinoma; Non-Invasive Bladder Urothelial CarcinomaLast Updated:February 13, 2024Recruiting
Condition(s):Poisoning by BCG VaccineLast Updated:May 28, 2015Completed
Condition(s):Urothelial CancerLast Updated:December 28, 2023Active, not recruiting
Condition(s):Kidney Cancer; Renal Cell Carcinoma; Clear Cell Carcinoma; Urothelial Carcinoma; Metastatic Kidney Cancer; Metastatic Urothelial Carcinoma; Papillary Renal Cell Carcinoma; Chromophobe Renal Cell Carcinoma; Fumarate Hydratase Deficiency; Succinate Dehydrogenase-Deficient Renal Cell Carcinoma; HLRCC; Hereditary Leiomyomatosis and Renal Cell CancerLast Updated:December 13, 2023Recruiting
Condition(s):Cancer; Deep Venous Thrombosis; Pulmonary EmbolismLast Updated:January 18, 2017Completed
Condition(s):Transitional Cell Carcinoma of Urinary TractLast Updated:December 30, 2014Completed
Condition(s):Urothelial Carcinoma; Cholangiocarcinoma; Cervical Cancer; Squamous Cell Carcinoma of Head and NeckLast Updated:April 14, 2016Terminated
Condition(s):Renal Carcinoma; Renal Cell Carcinoma; Urothelial CarcinomaLast Updated:March 19, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.